# Plasma Rich in Growth Factors (PRGF) for the Treatment of Lichen Sclerosus Atrophicus of the Vulva

> **NCT05364515** · PHASE3 · WITHDRAWN · sponsor: **Fundación Eduardo Anitua**

## Conditions studied

- Lichen Sclerosus of Vulva

## Interventions

- **DRUG:** PRGF
- **DRUG:** Clobetasol Propionate

## Key facts

- **NCT ID:** NCT05364515
- **Lead sponsor:** Fundación Eduardo Anitua
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-12-23
- **Primary completion:** 2024-02-15
- **Final completion:** 2024-02-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The PI left the participating center and, due to the care load of the service to which she belonged, no clinician was able to take charge of the clinical trial. The clinical trial was never started, no participating subjects were included.
- **Last updated:** 2025-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05364515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05364515, "Plasma Rich in Growth Factors (PRGF) for the Treatment of Lichen Sclerosus Atrophicus of the Vulva". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05364515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*